Bank Julius Baer & Co’s STAAR Surgical STAA Stock Holding History

Bank Julius Baer & Co’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-180	Closed	-$16K	–	782
2021 Q4	$16K	Buy	+180	New	+$19.3K	﹤0.01%	761

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Bank Julius Baer & Co's STAA Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of STAAR Surgical (STAA) in Q1 2022, closing a stake of 180 shares — an estimated $16K sold.

Bank Julius Baer & Co first reported a position in STAA in Q4 2021 and held it in 1 quarter. The position peaked at $16K in Q4 2021. 270 funds tracked by Wall St. Rank hold STAA as of Q1 2022.

Bank Julius Baer & Co reported no remaining STAAR Surgical position as of Q1 2022 after selling out during the quarter.
Bank Julius Baer & Co sold 180 STAAR Surgical shares in Q1 2022, an estimated $16K.
Bank Julius Baer & Co first reported a position in STAAR Surgical in Q4 2021 and held it in 1 quarter.
Bank Julius Baer & Co's STAAR Surgical position peaked at $16K in Q4 2021.
270 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.